Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. (Q47887100)

6 February 2018

title

Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. (English)

1 reference

6 February 2018

0 references

4

S Dimmeler

1 reference

6 February 2018

author name string

D H Walter

1

1 reference

6 February 2018

V Schächinger

2

1 reference

6 February 2018

M Elsner

3

1 reference

6 February 2018

A M Zeiher

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

6 February 2018

published in

The Lancet

1 reference

6 February 2018

volume

350

1 reference

6 February 2018

page(s)

1217-1219

1 reference

6 February 2018

issue

9086

1 reference

6 February 2018

A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Stent thrombosis. Closing in on the best preventive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Glycoprotein IIIa polymorphism and risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regime

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2905399-3

7 January 2021

10.1016/S0140-6736(97)05399-3

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9652563

1 reference

6 February 2018